Results 161 to 170 of about 582,605 (264)

Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

open access: yesMolecular Oncology, EarlyView.
Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker   +14 more
wiley   +1 more source

Effect of advancing age on event-related potentials (P300) measures

open access: yesThe Egyptian Journal of Otolaryngology
Background Aging has been defined as a persistent deterioration in the age-specific fitness components of an organism, attributed to internal physiological degeneration.
Archisman Shubhadarshan, Uneza Gaiwale
doaj   +1 more source

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

open access: yesMolecular Oncology, EarlyView.
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen   +13 more
wiley   +1 more source

Transmission through Cantor structured Dirac comb potential [PDF]

open access: yesarXiv
In this study, we introduce the Cantor-structured Dirac comb potential, referred to as the Cantor Dirac comb (CDC-$\rho_{N}$) potential system, and investigate non-relativistic quantum tunneling through this novel potential configuration. This system is engineered by positioning delta potentials at the boundaries of each rectangular potential segment ...
arxiv  

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha   +6 more
wiley   +1 more source

Event-Related Potential Prolongation in Alzheimer's Disease Signifies Frontal Lobe Impairment: Evidence From SPECT Imaging [PDF]

open access: bronze, 1996
Deirdre O’Mahony   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy